← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Albany College Of Pharmacy
Albany, NY
$19,266,311
Total funding
27
Grants
Funding over time
peak $2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,366,378 · 25
FDA$499,999 · 1
NSF$399,934 · 1
By mechanism
R01$9,992,282 · 10
R15$7,354,970 · 11
R21$1,019,126 · 4
U01$499,999 · 1
—$399,934 · 1
Investigators at Albany College Of Pharmacy
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
Discovery and development of novel glycine transporter-2 inhibitors for the treatment of neuropathic pain$534,125
R01 · FY2019 · DA
An in vitro-in vivo correlation model to predict serum non-transferrin bound iron$499,999
U01 · FY2013 · FD
Investigating RNA polymerase III driven mechanisms in regulating HIV latency$495,321
R15 · FY2022 · AI
Deciphering the molecular mechanisms of histone code recognition by ATAD2/B$481,491
R01 · FY2020 · GM
Repression of Inflammasome by Francisella tularensis$480,000
R15 · FY2017 · AI
Repression of inflammasome by Francisella tularensis$480,000
R15 · FY2020 · AI
Simultaneous Determination of Free, Total, and Normalized Concentrations of Bioactive Compounds$480,000
R15 · FY2018 · GM
Targeting secreted factors in endocrine resistant breast cancer therapy$480,000
R15 · FY2023 · CA
Mechanisms and outcomes of erythrocyte necroptosis$480,000
R15 · FY2017 · HL
Mechanisms of chromatin binding and selection by family IV bromodomains$480,000
R15 · FY2016 · GM
Solid Phase Microextraction as a New Tool for Quantifying Antibody Drugs in Breast Cancer and Building PK-PD models$480,000
R15 · FY2024 · CA
Novel Probes for Sirtuins: A Chemical Biology Approach$480,000
R15 · FY2017 · GM
Mechanisms and outcomes of the hyperglycemic shift to necroptosis in myeloid cells$480,000
R15 · FY2021 · HL
Repression of inflammasome by Francisella tularensis$480,000
R15 · FY2024 · AI
Activation of type I interferon production in human immune cells by cell-to-cell transmission of HIV-1$479,925
R15 · FY2025 · AI
Deciphering the molecular mechanisms of histone code recognition by ATAD2/B$478,681
R01 · FY2019 · GM
Repression of inflammasome by Francisella tularensis$465,000
R15 · FY2013 · AI
Deciphering the molecular mechanisms of histone code recognition by ATAD2/B$454,712
R01 · FY2018 · GM
Codrugs of Lipoic Acid and Tocopherol/Tocopheramine for Use as Photoprotective Ag$453,896
R15 · FY2011 · AR
Discovery and development of novel glycine transporter-2 inhibitors for the treatment of neuropathic pain$430,744
R01 · FY2021 · DA